1.A Case of Tubo - Pelvic Actinomycosis.
Ho Ju YOON ; Bum KIM ; Sang Hyn LEE ; Hyun Ah JUN ; Jwa Goo JUNG
Korean Journal of Obstetrics and Gynecology 1999;42(2):416-419
Pelvic actinomycosis is a rare disease, and has variable clinical manifestations and courses, which make it difficult to diagnose the disease initially. We experienced a pelvic actinomycosis in a woman who complained vaginal discharge and lower abdominal pain, and had not been carring a intrauterine contraceptive device. This infection results in tissue destruction, fibrosis, and the formation of draining sinuses. We describe the case with brief review of clinical diagnosis and management.
Abdominal Pain
;
Actinomycosis*
;
Diagnosis
;
Female
;
Fibrosis
;
Humans
;
Intrauterine Devices
;
Rare Diseases
;
Vaginal Discharge
2.Clinical study of treatment of ischemic limb aided by measurement of segmental blood pressure by doppler.
Bum Goo LEE ; Young Ju KIM ; Suk Woung YOON ; Hung Gi PARK
The Journal of the Korean Orthopaedic Association 1992;27(7):1701-1705
No abstract available.
Blood Pressure*
;
Extremities*
3.Prognostic Significance of Prostate-specific Antigen Level Two Months after Maximal Androgen Blockade in Metastatic Prostate Cancer.
Bum Jin PARK ; Young Goo LEE ; Hye Kyung AHN
Korean Journal of Urology 2003;44(9):855-860
PURPOSE: The aim of this study was to analyze the prognostic significance of pre- and post-treatment serum prostate-specific antigen (PSA) level, together with a variety of other clinicopathological parameters, in patients with metastatic prostate cancer receiving maximal androgen blockade (MAB). MATERIALS AND METHODS: The PSA levels before and during MAB, together with various clinicopathological parameters, were measured in 65 patients with newly diagnosed metastatic prostate cancer. The prognostic significance of these parameters, including the PSA level two and six months after MAB (PSA2MO and PSA6MO), a 50% reduction in the pretreatment PSA level after MAB (PSA50), the extent of disease (EOD), performance state, Gleason score and pretreatment hemoglobin, were analyzed by both univariate and multivariate tests. RESULTS: Of the forty-nine patients with a pretreatment PSA level of > or =50ng/ml, twenty-four (24/49, 48.9%) showed normalized (< or =4ng/ml) PSA2MO, and three of these (3/24, 12.5%) died of metastatic prostate cancer. Twenty-five patients (25/49, 51.1%) showed no normalization of the PSA2MO, and sixteen of these (16/25, 64%) died of metastatic prostate cancer. Of the patients with a pretreatment PSA level > or =50ng/ml, patients with a normalized PSA2MO showed a higher survival rate than those with a non-normalized PSA2MO from the univariate analysis using the Log-Rank test (p=0.0001), and PSA2MO was revealed as the most useful prognostic factor (p=0.022) from the multivariate analysis using the Cox proportional hazards regression model. CONCLUSIONS: A normalized (< or =4ng/ml) PSA level 2 months after MAB (PSA2MO) in metastatic prostate carcinoma was found to be the most useful prognostic factor in metastatic prostate cancer patients with a pretreatment PSA level of > or =50ng/ml.
Androgen Antagonists
;
Humans
;
Multivariate Analysis
;
Neoplasm Grading
;
Prostate*
;
Prostate-Specific Antigen*
;
Prostatic Neoplasms*
;
Survival Rate
4.Mammary Adenomyoepithelioma in Male Patient.
Keun Won RYU ; Aeree KIM ; Chul Hwan KIM ; Jae Bok LEE ; Eun Sook LEE ; Jung Won BAE ; Bum Hwan GOO
Journal of Korean Breast Cancer Society 2000;3(1):76-79
Myoepithelial cells are the normal constituent of mammary gland and the lesions arising from this components are rare and can be divided into three categories. Adenomyoepithelioma, which is one of them, has a characteristics of dual proliferation of epithelial and myoepithelial cells but the biologic behavior of it has not yet been fully understood. Most of the adenomyoepitheliomas are reported in female patients and there are few of male patient reported in English literature. We experienced one case of male adenomyoepithelioma and report the case with review of literature.
Adenomyoepithelioma*
;
Female
;
Humans
;
Male*
;
Mammary Glands, Human
5.Analysis of Hormone Receptor between IHC and EIA in Breast Cancer.
Yong Geul JOH ; Jeoung Won BEA ; Jun Won UM ; Eun Sook LEE ; Jae Bok LEE ; Han Kyeom KIM ; Bum Hwan GOO
Journal of Korean Breast Cancer Society 1999;2(2):159-166
PURPOSE: This study was prospectively carried out to determine the concordance between the immunohistochemical assay (IHC) and the enzyme immunoassay (EIA) assessing estrogen receptor (ER) and progesteron receptor (PR) in breast cancer tissues. MATERIALS AND METHODS: Breast carcinoma tissues were obtained from 36 patients. Hormonal receptors were determined by IHC assay using polyclonal antimouse antibody and by EIA. The concordance between two methods and the concordance according to in age, tumor size, stage, and lymph node metastasis of breast cancer patient were analyzed. RESULTS: The concordant rate of ER status was 88.9% between IHC and EIA. ER-IHC(+)/EIA(-) were 3 cases and ER-IHC(-)/EIA(+) was 1 cases. ER-positive was 63.9% in IHC and 53.8% in EIA. The concordant rate of PR status was 86.1% between IHC an EIA. PR-IHC(+)/EIA(-) were 4 cases and PR-IHC(-)/EIA(+) was 1 cases. PR-positive was 61.1% in IHC and 52.8% in EIA. There was high concordance (76.2-100%) in age, tumor size, stage, and lymph node metastasis. CONCLUSIONS: There was high concordance between immunohistochemical assay and enzymeimmunoassay determining estrogen and progesteron receptors in the breast cancer. The IHC assay appears to be a resonable substitute for the EIA to determine hormonal receptors.
Breast Neoplasms*
;
Breast*
;
Estrogens
;
Humans
;
Immunoenzyme Techniques
;
Lymph Nodes
;
Neoplasm Metastasis
;
Prospective Studies
6.Identification of 10 Candidate Biomarkers Distinguishing Tuberculous and Malignant Pleural Fluid by Proteomic Methods.
Chang Youl LEE ; Ji Young HONG ; Myung Goo LEE ; In Bum SUH
Yonsei Medical Journal 2017;58(6):1144-1151
PURPOSE: Pleural effusion, an accumulation of fluid in the pleural space, usually occurs in patients when the rate of fluid formation exceeds the rate of fluid removal. The differential diagnosis of tuberculous pleurisy and malignant pleural effusion is a difficult task in high tuberculous prevalence areas. The aim of the present study was to identify novel biomarkers for the diagnosis of pleural fluid using proteomics technology. MATERIALS AND METHODS: We used samples from five patients with transudative pleural effusions for internal standard, five patients with tuberculous pleurisy, and the same numbers of patients having malignant effusions were enrolled in the study. We analyzed the proteins in pleural fluid from patients using a technique that combined two-dimensional liquid-phase electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry. RESULTS: We identified a total of 10 proteins with statistical significance. Among 10 proteins, trasthyretin, haptoglobin, metastasis-associated protein 1, t-complex protein 1, and fibroblast growth factor-binding protein 1 were related with malignant pleural effusions and human ceruloplasmin, lysozyme precursor, gelsolin, clusterin C complement lysis inhibitor, and peroxirexdoxin 3 were expressed several times or more in tuberculous pleural effusions. CONCLUSION: Highly expressed proteins in malignant pleural effusion were associated with carcinogenesis and cell growth, and proteins associated with tuberculous pleural effusion played a role in the response to inflammation and fibrosis. These findings will aid in the development of novel diagnostic tools for tuberculous pleurisy and malignant pleural effusion of lung cancer.
Biomarkers*
;
Carcinogenesis
;
Ceruloplasmin
;
Chaperonin Containing TCP-1
;
Clusterin
;
Diagnosis
;
Diagnosis, Differential
;
Electrophoresis
;
Fibroblasts
;
Fibrosis
;
Gelsolin
;
Haptoglobins
;
Humans
;
Inflammation
;
Lung Neoplasms
;
Methods*
;
Muramidase
;
Pleural Effusion
;
Pleural Effusion, Malignant
;
Prevalence
;
Proteomics
;
Spectrum Analysis
;
Tuberculosis
;
Tuberculosis, Pleural
7.Morphologic change of pulmonary arteries and right ventricular outflow tract after total correction of tetralogy of Fallot: risk factors for pulmonary artery junctional stenosis.
Jin Sung KO ; Jae Young CHOI ; Jong Kyun LEE ; Kyung Eun KIM ; Jun Hee SUL ; Seung Kyu LEE ; Young Hwan PARK ; Bum Goo CHO
Korean Circulation Journal 2001;31(2):238-245
BACKGROUND AND OBJECTIVES: Recently, the result of total correction in tetralogy of Fallot(TOF) is improved dramatically. But, residual anatomical changes of right ventricular outflow tract(RVOT) and pulmonary artery junctional stenosis result in bad prognosis. Therefore we sought to analyze risk factors for pulmonary artery junctional stenosis after correction of TOF. METHODS: From 1991 to 1998, 146 patients underwent the follow-up catheterizations after total correction of TOF in our institution and were analysed risk factors for pulmonary artery junctional stenosis. Of this patients group [age on operation 20.119.8 months, follow-up duration after operation 13.95.0 months, male(64%)], 20 cases(13.7%) had a PDA and 26 cases(17.8%) had a systemic-to-pulmonary shunt operation before total correction of TOF. RESULTS: 1) Residual PS is correlated significantly with post-operative RVP/LVP(r=.776, p<0.01) and post-operative RVEDP(r=.196, p<0.05). 2) Post-operative RVP/LVP and residual PS increased significantly in grade II of residual PI than grade III~IV. 3) The left pulmonary artery junctional stenosis(LPAJS) was observed in 31 cases, this group decreased significantly in pre-operative LPA diameter(p<0.01), increased in post-operative RVP/LVP(p<0.01), and increased in post-operative RPA diameter(p<0.01), decreased in post-operative LPA diameter(p<0.01) and was more severe in post-operative PI(p<0.01) than the other group respectively. 4) Of the patients group which went patch enlargement of RVOT to LPA junction, the pressure gradient on LPA junction increased significantly in PDA and false aneurysmal change. 5) Factors significantly associated with pulmonary artery junctional stenosis were patch enlargement of RVOT to LPA junction, aneurysmal change of RVOT, PDA, systemic-to-pulmonary shunt and pre-operative LPAJS. 6) LPAJS(P, mmHg) =5.43 +16.24*[false aneurysmal change of RVOT] +14.13*[RVOT patch enlargement to LPA] +16.89*PDA. CONCLUSION: Several factors significantly associated with pulmonary artery junctional stenosis influenced each other. And the LPAJS led to secondary changes (volume overload of RV, increasing diameter of RPA, et. al) therefore more active diagnosis and treatment after total correction is recommended.
Aneurysm
;
Aneurysm, False
;
Catheterization
;
Catheters
;
Constriction, Pathologic*
;
Diagnosis
;
Follow-Up Studies
;
Humans
;
Prognosis
;
Pulmonary Artery*
;
Risk Factors*
;
Tetralogy of Fallot*
8.Left ventricular function after mitral valve operation in congenital mitral regurgitation.
Young Min EUN ; Jae Young CHOI ; Jong Kyun LEE ; Jun Hee SUL ; Seung Kyu LEE ; Young Hwan PARK ; Bum Goo CHO
Korean Circulation Journal 2000;30(6):737-744
BACKGROUND: Severe mitral regurgitation is a common clinical entity that can lead to progressive, irreversible left ventricular dysfunction, and thus should be corrected in proper stage of life. Authors have conducted this investigation to assess left ventricular function after mitral valve operation and to determine the predicting factors. METHODS AND RESULTS: The echocardiographic parameters, specifically left ventricular ejection fraction, shortening fraction, end-systolic dimension and volume, and end-diastolic dimension and volume were measured in preoperative and postoperative period of congenital mitral regurgitation patients (n=60), between March 1992 and March 1998. After correction of severe mitral regurgitaion, left ventricular ejection fraction and shortening fraction decreased significantly (p<0.001 and p<0.05 respectively). Furtheremore, after reoperation of recurred mitral regurgitation, left ventricular ejection fraction and shortening fraction decreased significantly (p<0.05). Left ventricular ejection fraction and shortening fraction in mitral valve reoperation group (n=23) is significantly lower than those in non-reoperation group (n=37) in both preoperative and postoperative period (p<0.05). Left ventricular ejection fraction and shortening fraction is also significantly lower in mitral valve replacement group (n=20) than in mitral valvuloplasty group (n=40)(p<0.05). Severe postoperative left ventricular dysfunction led to dilated cardiomyopathy in 5 patients. Postoperative left ventricular end systolic dimension increased significantly in reoperation group and DCMP group respectively (p<0.05). CONCLUSION: After surgical correction of mitral regurgitation, left ventricular dysfunction is frequent and carries a poor prognosis. Postoperative left ventricular dysfunction can be predicted by preoperative ejection fraction, shortening fraction and systolic diameter. Therefore surgical therapy before the onset of left ventricular dysfunction is recommended.
Cardiomyopathy, Dilated
;
Deoxycytidine Monophosphate
;
Echocardiography
;
Humans
;
Mitral Valve Insufficiency*
;
Mitral Valve*
;
Postoperative Period
;
Prognosis
;
Reoperation
;
Stroke Volume
;
Ventricular Dysfunction, Left
;
Ventricular Function, Left*
9.Influence of Ureteral Stone Components on the Outcomes of Electrohydraulic Lithotripsy.
Hyeong Cheol SONG ; Ha Bum JUNG ; Yong Seong LEE ; Young Goo LEE ; Ki Kyung KIM ; Sung Tae CHO
Korean Journal of Urology 2012;53(12):848-852
PURPOSE: We evaluated the influence of urinary stone components on the outcomes of ureteroscopic removal of stones (URS) by electrohydraulic lithotripsy (EHL) in patients with distal ureteral stones. MATERIALS AND METHODS: Patients with a single distal ureteral stone with a stone size of 0.5 to 2.0 cm that was completely removed by use of EHL were included in the study. Operating time was defined as the time interval between ureteroscope insertion and complete removal of ureteral stones. Ureteral stones were classified into 5 categories on the basis of their main component (that accounting for 50% or more of the stone content) as follows: calcium oxalate monohydrate (COM), calcium oxalate dihydrate, carbonate apatite (CAP), uric acid (UA), and struvite (ST). RESULTS: A total of 193 patients (131 males and 62 females) underwent EHL. The mean operating time was 25.1+/-8.2 minutes and the mean stone size was 1.15+/-0.44 cm. Calcium oxalate stones accounted for 64.8% of all ureteral stones, followed by UA (19.7%), CAP (8.3%), and ST (7.2%) stones. The mean operating time was significantly longer in the UA group (28.6+/-8.3 minutes) than in the COM group (24.0+/-7.8 minutes, p=0.04). In multivariate analyses, the stone size was negatively associated with the odds ratio (OR) for successful fragmentation. UA as a main component (OR, 0.42; 95% confidence interval, 0.20 to 0.89; p=0.023) was also found to be significantly important as a negative predictive factor of successful fragmentation after adjustment for stone size. CONCLUSIONS: The results of the present study suggest that successful fragmentation by URS with EHL could be associated with the proportion of the UA component.
Accounting
;
Apatites
;
Calcium Oxalate
;
Carbon
;
Humans
;
Lithotripsy
;
Magnesium Compounds
;
Male
;
Multivariate Analysis
;
Odds Ratio
;
Phosphates
;
Ureter
;
Ureteroscopes
;
Ureteroscopy
;
Uric Acid
;
Urinary Calculi
10.Mode of Parotid Invasion and Parotid Lymph Node Metastasis in External Auditory Canal Carcinoma.
Jae Young CHOI ; Ho Ki LEE ; Jong Bum RYU ; Sun Goo KIM ; Mee Hyun SONG ; Kyo Bum CHOO ; Won Sang LEE
Korean Journal of Otolaryngology - Head and Neck Surgery 2004;47(2):99-102
BACKGROUND AND OBJECTIVES: Until now, only a little is known about the mode of parotid involvement in external auditory canal (EAC) carcinoma. We examined the incidence of parotid node metastasis and direct parotid invasion in patients with EAC carcinoma. The purpose of this study was to evaluate the role of parotidectomy and to provide the guidelines for performance of parotidectomy when dealing with EAC carcinoma. MATERIALS AND METHOD: The study comprised of 11 patients with squamous cell carcinomas (SCC) and 10 patients with adenoid cystic carcinomas (ACC). A retrospective review of the surgical specimens was undertaken with specific reference to parotid node metastasis and parotid invasion. RESULTS: Parotid node metastasis was noted only in two cases of advanced staged SCC, whereas none of the ACC patients showed parotid node metastasis. Direct parotid invasion occurred only in advanced staged SCC;however, it did occur in early stage ACC. CONCLUSION: Our data indicated that elective parotidectomy for control of occult parotid node metastasis is necessary only in advanced SCC carcinoma, whereas parotid management to secure adequate safety margin is mandatory for advanced SCC and all cases of ACC.
Carcinoma, Adenoid Cystic
;
Carcinoma, Squamous Cell
;
Ear Canal*
;
Humans
;
Incidence
;
Lymph Nodes*
;
Neoplasm Metastasis*
;
Parotid Gland
;
Retrospective Studies